CTNM vs RL · $429.6M cap vs P/E 24, rev $8.11B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
CTNM currently screens at market cap $429.6M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the CTNM and RL stock pages for the full models.
Not investment advice.